The Food and Drug Administration (FDA) recently discovered that “microdosing” chocolate bars intended to provide consumers with “peace of mind” are sending an increasing number of individuals to the hospital.
On June 7, the FDA issued a first advisory notice regarding Diamond Shruumz, a manufacturer of “microdosing” chocolate bars and gummies. At the time, six people who had consumed the items were admitted to hospital.
The FDA now states that at least ten people have been hospitalized after consuming the items. A further two people sought medical attention but were not hospitalized. “Do not eat, sell, or serve Diamond Shruumz-Brand Microdosing Chocolate Bars,” the FDA’s website states.
- California RESIDENTS To RECEIVE $500 MONTHLY PAYMENTS In New Guaranteed Income Program: Here Is Who Is Eligible
- Us Job Market Booms With 272,000 New Jobs, But Unemployment Rises Slightly To 4.0%
- Credit Scores Of 720+ See Improved Loan Rates This Week
- Examining The Facts: Fact Check On IRS $8700 Stimulus Check Eligibility & Payment Dates
- Gas Prices On Downward Trend As Fourth Of July Road Trips Approach: AAA
“[The] FDA is working to determine the cause of these illnesses and is considering the appropriate next steps,” the statement continued. “More information will be provided as it becomes available.”
The items are available nationwide. According to the FDA website, hospitalizations have been reported in Alabama, Kentucky, Missouri, Nevada, South Carolina, and Pennsylvania. Arizona recorded four hospitalizations, while Indiana reported two.
Consumers who ate the “microdosing” items experienced “severe” symptoms, according to officials.
“People who became ill after eating Diamond Shruumz-brand Microdosing Chocolate Bars reported a variety of severe symptoms including seizures, central nervous system depression (loss of consciousness, confusion, sleepiness), agitation, abnormal heart rates, hyper/hypotension, nausea, and vomiting,” according to the Food and Drug Administration.
“Microdosing” occurs when drug users take a small amount of hallucinogenic drugs to boost their creativity and mood without experiencing a psychedelic trip. Even though the Diamond Shruumz products are billed as “microdosing,” the business claims that they contain no psilocybin.
“There is no presence of psilocybin, amanita, or any scheduled drugs, ensuring a safe and enjoyable experience,” Diamond Shruumz’s website states. “Rest assured, our treats are not only free from psychedelic substances but our carefully crafted ingredients still offer an experience.”
“This allows you to indulge in a uniquely crafted blend designed for your pleasure and peace of mind.”
The FDA and Centers for Disease Control and Prevention are looking into the items. Fox News Digital contacted Diamond Shruumz for comment but did not receive a response.